The findings of this study suggest that serum SOD1 concentration could be included in the routine clinical characteristics of lung cancer patients as an additional diagnostic and prognostic biomarker; however, this still required corroboration by further, more detailed studies with larger cohorts. The gene discussed is SOD1; the disease is lung carcinoma.